RIGEL PHARMACEUTICALS INC (RIGL)

US7665596034 - Common Stock

1.13  -0.01 (-0.88%)

After market: 1.13 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
116.88M120.20M149.20M108.60M59.30M
Cost Of Goods
7.11M1.70M1.10M900.00K900.00K
Gross Profit
109.77M118.50M148.20M107.70M58.40M
Operating Expenses
130.26M172.80M157.10M136.70M127.50M
Research and Development
24.52M60.30M65.20M60.10M52.90M
Selling, General, and Administrative Expenses
105.74M112.50M91.90M76.60M74.60M
Operating Income
-20.49M-54.30M-9.00M-29.00M-69.10M
Interest Income/Expense
-4.60M-3.00M-4.80M-800.00K2.20M
Non Recurring Items
N/A-1.30M-3.50MN/AN/A
Income Before Taxes
-25.09M-58.60M-17.30M-29.70M-66.90M
Income Tax
N/A0.00600.00KN/AN/A
Net Income
-25.09M-58.60M-17.90M-29.70M-66.90M
EBITDA
-19.25M-53.30M-7.84M-28.29M-68.42M
 
Per Share Data
EPS Diluted Total Ops
-0.14-0.34-0.11-0.18-0.40
Non GAAP EPS
-0.15-0.34-0.11-0.16-0.40
 
Statistics
Gross Profit Margin
93.92%98.59%99.33%99.17%98.48%
Profit Margin
-21.47%-48.75%-12.00%-27.35%-112.82%
Operating Profit Margin
-17.53%-45.17%-6.03%-26.70%-116.53%

All data in USD

Charts